CD7 CAR-T: a bridge to transplant in AML

被引：0
|
作者：
Mamonkin, Maksim [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
BLOOD | 2025年 / 145卷 / 10期
关键词：
THERAPY; 1ST-IN-HUMAN; CELLS;
D O I：
10.1182/blood.2024027442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Lu et al1 report early results from a phase 1 study of autologous CD7 chimeric antigen receptor-modified T cells (CD7 CAR-T) in patients with acute myeloid leukemia (AML). The authors describe the safety and preliminary efficacy of CD7 CAR-T, which induced disease remission in most patients. However, the responses were durable only in those who received subsequent allogeneic hematopoietic stem cell transplant (alloHSCT).
引用
收藏
页码：995 / 996
页数：2
相关论文
共 50 条
  • [41] Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7
    Hirai, K
    Torimoto, Y
    Moriichi, K
    Sato, K
    Ohnishi, K
    Taya, N
    Kohgo, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (01) : 30 - 35
  • [42] THE ROLE OF CD7 IN T-CELL ACTIVATION
    CHAKKALATH, HR
    JUNG, LKL
    FASEB JOURNAL, 1991, 5 (05): : A992 - A992
  • [43] CAR-T cell therapy in AML: recent progress and future perspectives
    Saito, Shoji
    Nakazawa, Yozo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (04) : 455 - 466
  • [44] Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
    Wu, Huantong
    Xu, Zhuofan
    Qi, Maoyang
    Liu, Penghao
    Zhang, Boyan
    Wang, Zhenglin
    Chen, Ge
    Liu, Xiaohai
    Liu, Junqi
    Wei, Wei
    Duan, Wanru
    Chen, Zan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
  • [45] Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML
    Bernasconi-Bisio, Franco
    Molina, Eva
    Ibarra, Vianca
    Ibanez-Sala, Ines
    Rochira, Federica
    Jauregui, Patricia
    Rodriguez-Diaz, Saray
    Martinez-Turrillas, Rebeca
    Azagra-Barber, Inigo
    Gomez-Cebrian, Nuria
    Jose Lasarte, Juan
    Puchades-Carrasco, Leonor
    Vanrell, Lucia
    Roberto Rodriguez-Madoz, Juan
    Prosper, Felipe
    Pineda-Lucena, Antonio
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [46] Interpreting Immune Reconstitution and Clinical Outcome By Single-Cell Transcriptomic Analysis in T-ALL Patients Undergoing Donor-Derived CD7 CAR-T Immunotherapy
    Shi, Hui
    Hu, Kai
    Yang, Fan
    Liu, Zhuojun
    Liu, Jia
    Chen, Wei
    Yu, Jian
    BLOOD, 2022, 140 : 10422 - 10423
  • [47] CLINICAL RELEVANCE OF CD7 EXPRESSION IN ACUTE MYELOID-LEUKEMIA (AML)
    DELPOETA, G
    STASI, R
    VENDITTI, A
    SIMONE, MD
    MASI, M
    TRIBALTO, M
    PAPA, G
    BLOOD, 1993, 82 (10) : A123 - A123
  • [48] Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML
    Wermke, Martin
    Kraus, Sabrina
    Ehninger, Armin
    Bargou, Ralf C.
    Goebeler, Maria-Elisabeth
    Middeke, Jan Moritz
    Kreissig, Carla
    von Bonin, Malte
    Koedam, Jan
    Pehl, Michael
    Bornhaeuser, Martin
    Einsele, Hermann
    Ehninger, Gerhard
    Cartellieri, Marc
    BLOOD, 2021, 137 (22) : 3145 - 3148
  • [49] Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
    Chen, Wei
    Shi, Hui
    Liu, Zhuojun
    Yang, Fan
    Liu, Jia
    Zhang, Leqiang
    Wu, Yajin
    Xia, Yuanshi
    Ou, Yuxuan
    Li, Ruiting
    Zhang, Ting
    Zhang, Jiecheng
    Ke, Xiaoyan
    Hu, Kai
    Yu, Jian
    CLINICAL CANCER RESEARCH, 2023, 29 (08) : 1484 - 1495
  • [50] CD7 - A REVIEW
    CHANG, KL
    WEISS, LM
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 146 - 156
12345